Begin main content

Glucose Replacement Agents in Frail Elderly Patients with Type II Diabetes in Long-Term Care: Clinical and Cost-Effectiveness, Harms, and Guidelines

Published on: January 13, 2015
Project Number: RB0778-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of glucose replacement agents in frail elderly patients with type II diabetes who reside in long-term care (LTC) facilities?
  2. What are the harms associated with glucose replacement agents in frail elderly patients with type II diabetes who reside in LTC facilities?
  3. What is the cost-effectiveness of using glucose replacement agents in frail elderly patients with type II diabetes who reside in LTC facilities?
  4. What are the evidence-based guidelines regarding the use of glucose replacement agents in frail elderly patients with type II diabetes who reside in LTC facilities?

Key Message

No health technology assessment reports, systematic reviews, meta-analyses, randomized controlled trials, non-randomized studies, economic evaluations, or evidence-based guidelines were identified regarding glucose replacement agents in frail elderly patients with type II diabetes who reside in long-term care facilities.

Tags

aged, diabetes mellitus, geriatrics, glucose, homes for the aged, housing for the elderly, hypoglycemia, long-term care, nursing homes, diabetes, Hypoglycaemia, hypoglycaemic, Hypoglycemic, longterm care, low blood sugar, 80 and over, Type 2